Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LENZLENZ Therapeutics, Inc.

Nasdaq · CIK 0001815776
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts263

Identity from submissions API

NameLENZ Therapeutics, Inc.
CIK0001815776
TickersLENZ
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN844867570
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone858-925-7000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Graphite Bio, Inc. (2021-03-19T04:00:00.000Z → 2024-03-19T04:00:00.000Z)
Business address
201 LOMAS SANTA FE DRIVE, SUITE 300
SOLANA BEACH
CA
92075
CA
Mailing address
201 LOMAS SANTA FE DRIVE, SUITE 300
SOLANA BEACH
CA
92075
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

359 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002766 005-92660 261526201 34 11692
2026-11-04 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001373604-26-000076 005-92660 261521892 34 7163
2026-11-03 4 FORM 4 0001706176-26-000007 6574
2026-11-03 10-Q 10-Q 0001815776-26-000059 001-40532 261517445 34 6189420 1 1
2026-11-02 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000251 005-92660 261513801 34 16547
2026-11-02 4 xslF345X06/form4-11022026_101120.xml 0001231919-26-001526 15143
2026-10-28 8-K 8-K 2.02,2.05,5.02,9.01 0001815776-26-000056 001-40532 261496290 34 304814 1 1
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-001098 005-92660 261490510 34 11129
2026-10-21 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-117887 005-92660 261476828 34 15515
2026-09-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002292 005-92660 261363756 34 11735
2026-08-11 10-Q 10-Q 0001815776-26-000052 001-40532 261263339 34 6075675 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001815776-26-000051 001-40532 261263228 34 266113 1 1
2026-07-02 8-K 8-K 5.02 0001815776-26-000046 001-40532 261152691 34 144488 1 1
2026-06-26 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-078313 005-92660 261130167 34 15886
2026-06-15 4 xslF345X06/form4-06162026_120622.xml 0001231919-26-000640 14606
2026-06-15 4 FORM 4 0001796789-26-000004 5884
2026-06-15 4 FORM 4 0001340881-26-000001 5883
2026-06-15 4 FORM 4 0001200889-26-000001 5880
2026-06-15 4 FORM 4 0001297491-26-000001 5857
2026-06-15 4 FORM 4 0001825009-26-000001 5869
2026-06-15 4 FORM 4 0001816523-26-000005 6623
2026-06-12 8-K 8-K 5.07 0001815776-26-000041 001-40532 261086690 34 154509 1 1
2026-05-11 10-Q 10-Q 0001815776-26-000037 001-40532 26963287 34 5366158 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001815776-26-000035 001-40532 26963214 34 236290 1 1
2026-04-28 ARS ARS 0001815776-26-000029 001-40532 26908720 34 38908108
2026-04-28 DEFA14A DEFA14A 0001815776-26-000028 001-40532 26908683 34 334710
2026-04-28 DEF 14A DEF 14A 0001815776-26-000026 001-40532 26908618 34 1590285 1 1
2026-04-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001701 005-92660 26901052 34 11175
2026-04-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001642575-26-000004 005-92660 26847754 34 22536
2026-03-30 4 FORM 4 0001796789-26-000003 5302
2026-03-30 4 FORM 4 0001713795-26-000004 5368
2026-03-30 4 FORM 4 0001706176-26-000004 4908
2026-03-24 S-8 S-8 0001815776-26-000013 333-294569 26786674 33 741411 1 1
2026-03-24 10-K 10-K 0001815776-26-000011 001-40532 26786281 34 22002383 1 1
2026-03-24 8-K 8-K 2.02,9.01 0001815776-26-000008 001-40532 26784243 34 265225 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016363 005-92660 26640756 34 10019
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000453 005-92660 26601934 34 11834
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000687 005-92660 26545865 34 11168
2026-01-07 8-K 8-K 2.02,9.01 0001815776-26-000003 001-40532 26516527 34 179152 1 1
2026-01-06 4 FORM 4 0002015796-26-000002 8814
2026-01-06 4 FORM 4 0002015900-26-000002 8815
2026-01-06 4 FORM 4 0001706176-26-000002 8811
2026-01-06 4 FORM 4 0001713795-26-000002 6068
2025-12-12 8-K 8-K 8.01 0001815776-25-000077 001-40532 251568261 34 146313 1 1
2025-11-19 4 FORM 4 0002015796-25-000003 11422
2025-11-17 144 xsl144X01/primary_doc.xml 0001950047-25-008982 001-40532 251491526 33 5226
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112625 005-92660 251487238 34 12654
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004990 005-92660 251485676 34 16988
2025-11-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-274461 005-92660 251467074 34 25131
2025-11-10 4 FORM 4 0001815776-25-000073 6038
2025-11-07 4 FORM 4 0001815776-25-000072 6134
2025-11-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-25-000043 005-92660 251463330 34 16965
2025-11-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002920 005-92660 251461155 34 11789
2025-11-05 10-Q 10-Q 0001815776-25-000071 001-40532 251454045 34 6678353 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001815776-25-000069 001-40532 251451918 34 240887 1 1
2025-10-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002599 005-92660 251401850 34 11117
2025-10-08 8-K 8-K 8.01 0001815776-25-000064 001-40532 251382788 34 144011 1 1
2025-10-02 4 4 0001193125-25-228493 30564
2025-09-30 8-K 8-K 7.01,8.01,9.01 0001815776-25-000062 001-40532 251358203 34 181823 1 1
2025-09-22 4 4 0001193125-25-211363 29915
2025-09-22 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-211357 005-92660 251330271 34 25351
2025-08-26 4 4 0000950170-25-111529 41134
2025-08-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-110483 005-92660 251237706 34 24764
2025-08-19 4 4 0000950170-25-110163 26378
2025-07-31 8-K 8-K 8.01,9.01 0001815776-25-000059 001-40532 251172438 34 182205 1 1
2025-07-30 10-Q 10-Q 0001815776-25-000056 001-40532 251166920 34 6510709 1 1
2025-07-30 8-K 8-K 2.02,9.01 0001815776-25-000054 001-40532 251164019 34 229749 1 1
2025-07-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-095617 005-92660 251122239 34 24266
2025-07-14 4 4 0000950170-25-095616 22038
2025-07-01 4 4 0000950170-25-092373 22588
2025-06-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-089455 005-92660 251069515 34 24331
2025-06-20 4 4 0000950170-25-088604 24372
2025-06-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-085511 005-92660 251043564 34 23963
2025-06-12 4 4 0000950170-25-085490 22035
2025-06-11 4 xslF345X05/form4-06112025_110656.xml 0001415889-25-016757 14213
2025-06-11 4 FORM 4 0001815776-25-000048 459318
2025-06-11 4 FORM 4 0001815776-25-000047 460105
2025-06-11 4 FORM 4 0001815776-25-000046 459412
2025-06-11 4 FORM 4 0001815776-25-000045 459270
2025-06-11 4 FORM 4 0001815776-25-000044 459795
2025-06-11 4 FORM 4 0001815776-25-000043 460083
2025-06-10 8-K 8-K 5.07 0001815776-25-000036 001-40532 251037838 34 158120 1 1
2025-05-09 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-012499 005-92660 25930711 34 21096
2025-05-07 10-Q 10-Q 0001815776-25-000032 001-40532 25921613 34 5877298 1 1
2025-05-07 8-K 8-K 2.02,9.01 0001815776-25-000030 001-40532 25921394 34 217840 1 1
2025-04-28 ARS ARS 0001193125-25-100677 001-40532 25880998 34 2529249
2025-04-28 DEFA14A DEFA14A 0001193125-25-100656 001-40532 25880915 34 359819
2025-04-28 DEF 14A DEF 14A 0001193125-25-100630 001-40532 25880845 34 1239852 1 1
2025-04-15 8-K 8-K 2.02,7.01,8.01 0001815776-25-000025 001-40532 25837707 34 156045 1 1
2025-04-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001108 333-286398 25837457 33 1962
2025-04-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001107 333-286397 25837456 33 1962
2025-04-14 424B5 424B5 0001628280-25-017695 333-286398 25836344 33 378236
2025-04-14 424B3 424B3 0001628280-25-017694 333-286397 25836341 33 320808
2025-04-10 CORRESP filename1.htm 0001628280-25-017367 11004
2025-04-10 CORRESP filename1.htm 0001628280-25-017365 10979
2025-04-10 UPLOAD filename1.pdf 0000000000-25-003839 333-286398 40328
2025-04-10 UPLOAD filename1.pdf 0000000000-25-003837 333-286397 40328
2025-04-09 4 FORM 4 0001815776-25-000022 7553
2025-04-09 424B3 424B3 0001628280-25-017190 333-282036 25825252 33 303510
2025-04-09 424B3 424B3 0001628280-25-017187 333-278393 25825236 33 315711
2025-04-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001031 333-282036 25823464 33 1975
2025-04-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001028 333-278393 25823461 33 1975
2025-04-04 8-K 8-K 1.01,9.01 0001628280-25-016824 001-40532 25815572 34 513869 1 1
2025-04-04 S-3 S-3 0001628280-25-016822 333-286398 25815555 33 1771670
2025-04-04 S-3 S-3 0001628280-25-016818 333-286397 25815529 33 960878
2025-04-04 POS AM POS AM 0001628280-25-016815 333-282036 25815520 33 391720
2025-04-04 POS AM POS AM 0001628280-25-016813 333-278393 25815509 33 405242
2025-03-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-028784 005-92660 25779592 34 16491
2025-03-19 S-8 S-8 0001628280-25-013856 333-285926 25753405 33 603633
2025-03-19 10-K 10-K 0001815776-25-000019 001-40532 25753284 34 19165162 1 1
2025-03-19 8-K 8-K 2.02,9.01 0001815776-25-000017 001-40532 25752752 34 236523 1 1
2025-03-07 4 FORM 4 0001815776-25-000011 7567
2025-01-13 4 FORM 4 0001815776-25-000009 435120
2025-01-13 4 FORM 4 0001815776-25-000007 435042
2025-01-13 4 FORM 4 0001815776-25-000005 433750
2025-01-13 4 FORM 4 0001815776-25-000003 434049
2024-12-17 4 FORM 4 0001815776-24-000074 7562
2024-11-14 SC 13G/A AMENDMENT NO. 1 0001214659-24-019109 005-92660 241461370 34 86541
2024-11-08 SC 13D/A SC 13D/A 0001193125-24-254239 005-92660 241441722 34 162326
2024-11-06 424B3 424B3 0001628280-24-045466 333-282036 241429321 33 1605168
2024-11-06 424B3 424B3 0001628280-24-045463 333-278393 241429300 33 1605215
2024-11-06 10-Q 10-Q 0001815776-24-000071 001-40532 241429257 34 6483928 1 1
2024-11-06 8-K 8-K 2.02,9.01 0001815776-24-000069 001-40532 241429239 34 235518 1 1
2024-10-28 424B3 424B3 0001628280-24-043870 333-282036 241398483 33 191403
2024-10-28 424B3 424B3 0001628280-24-043869 333-278393 241398481 33 191460
2024-10-28 8-K 8-K 8.01,9.01 0001815776-24-000064 001-40532 241398461 34 197282 1 1
2024-09-19 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-09-19 16:00:00 9999999995-24-002902 333-282036 241311574 33 1970
2024-09-19 424B3 424B3 0001628280-24-040949 333-282036 241311127 33 9070790
2024-09-17 CORRESP filename1.htm 0001628280-24-040600 10185
2024-09-13 UPLOAD filename1.pdf 0000000000-24-010420 333-282036 40398
2024-09-11 S-1 S-1 0001628280-24-040130 333-282036 241292700 33 24772692 1 1
2024-08-14 424B3 424B3 0001628280-24-037221 333-278393 241208435 33 1489591
2024-08-14 10-Q 10-Q 0001815776-24-000060 001-40532 241208030 34 6235663 1 1
2024-08-14 8-K 8-K 2.02,9.01 0001815776-24-000058 001-40532 241207665 34 272319 1 1
2024-08-12 424B3 424B3 0001628280-24-036611 333-278393 241194808 33 323194
2024-08-12 8-K 8-K 8.01,9.01 0001815776-24-000053 001-40532 241194794 34 173815 1 1
2024-07-29 SC 13G SC 13G 0001104659-24-083538 005-92660 241152486 34 81672
2024-07-23 4 FORM 4 0001815776-24-000051 433975
2024-07-15 424B3 424B3 0001628280-24-031841 333-278393 241115934 33 325020
2024-07-15 8-K 8-K 1.01,3.02,7.01,9.01 0001815776-24-000049 001-40532 241115912 34 178871 1 1
2024-05-21 S-8 S-8 0001628280-24-024451 333-279572 24966919 33 645743
2024-05-15 4 FORM 4 0001815776-24-000046 4745
2024-05-14 4 FORM 4 0001815776-24-000044 5833
2024-05-09 424B3 424B3 0001628280-24-022248 333-278393 24930966 33 1384990
2024-05-08 10-Q 10-Q 0001815776-24-000042 001-40532 24927449 34 5448529 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001815776-24-000039 001-40532 24925861 34 257512 1 1
2024-04-11 424B3 424B3 0001628280-24-015671 333-278393 24836880 33 6492540
2024-04-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-10 16:00:00 9999999995-24-000927 333-278393 24837026 33 1947
2024-04-09 S-1/A S-1/A 0001628280-24-015318 333-278393 24830732 33 22292630 1 1
2024-04-08 CORRESP filename1.htm 0001628280-24-015319 11011
2024-04-08 SC 13G/A grph13ga2.htm 0000935836-24-000347 005-92660 24829285 34 47400
2024-04-03 UPLOAD filename1.pdf 0000000000-24-003611 333-278393 40534
2024-04-03 8-K 8-K 8.01,9.01 0001815776-24-000035 001-40532 24816851 34 2093201 1 1
2024-03-29 S-1 S-1 0001628280-24-013816 333-278393 24804576 33 18290631 1 1
2024-03-28 3 xslF345X02/ownership.xml 0000902664-24-002662 11268
2024-03-28 SC 13G LENZ THERAPEUTICS, INC. 0000902664-24-002661 005-92660 24799562 34 91176
2024-03-28 SC 13D SC 13D 0001104659-24-040539 005-92660 24799166 34 123410
2024-03-25 4 xslF345X05/form4-03262024_120321.xml 0001415889-24-009077 29810
2024-03-25 3 xslF345X02/form3-03262024_120301.xml 0001415889-24-009075 10433
2024-03-25 4 FORM 4 0001815776-24-000029 5834
2024-03-25 SC 13G/A SC 13G/A 0001104659-24-038578 005-92660 24780704 34 112977
2024-03-25 4 FORM 4 0001815776-24-000028 13943
2024-03-25 4 FORM 4 0001815776-24-000027 11839
2024-03-25 4 xslF345X05/form4-03262024_120359.xml 0001415889-24-009073 6643
2024-03-25 4 FORM 4 0001815776-24-000026 241918
2024-03-25 3 xslF345X02/form3-03262024_120339.xml 0001415889-24-009071 3343
2024-03-25 4 FORM 4 0001815776-24-000025 5861
2024-03-25 4 FORM 4 0001815776-24-000023 6058
2024-03-25 4 FORM 4 0001815776-24-000022 14180
2024-03-25 4 FORM 4 0001815776-24-000021 11349
2024-03-25 4 FORM 4 0001815776-24-000020 14168
2024-03-25 3 FORM 3 0001815776-24-000019 238096
2024-03-25 3 FORM 3 0001815776-24-000018 238983
2024-03-25 3 FORM 3 0001815776-24-000017 238482
2024-03-25 3 FORM 3 0001815776-24-000016 237677
2024-03-25 3 FORM 3 0001815776-24-000015 237739
2024-03-25 3 FORM 3 0001815776-24-000014 237972
2024-03-25 3 FORM 3 0001815776-24-000012 237767
2024-03-25 3 FORM 3 0001815776-24-000011 235808
2024-03-25 SC 13D/A SC 13D/A 0001193125-24-076566 005-92660 24779854 34 182537
2024-03-25 SC 13G LENZ THERAPEUTICS, INC. 0000902664-24-002595 005-92660 24779692 34 113716
2024-03-25 4 4 0000950170-24-035951 22845
2024-03-25 3 3 0000950170-24-035939 9748
2024-03-22 8-K 8-K 2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,9.01 0001628280-24-012633 001-40532 24772814 34 3137475 1 1
2024-03-19 8-K 8-K 7.01,9.01 0001193125-24-071353 001-40532 24763890 34 163840 1 1
2024-03-14 8-K 8-K 5.07,9.01 0001193125-24-067966 001-40532 24750808 34 179350 1 1
2024-03-08 425 425 0001193125-24-063796 001-40532 24735587 34 51056
2024-03-08 8-K 8-K 7.01,9.01 0001193125-24-063785 001-40532 24735522 34 194653 1 1
2024-03-05 425 425 0001193125-24-058515 001-40532 24718185 34 46356
2024-03-05 8-K 8-K 8.01 0001193125-24-058513 001-40532 24718182 34 189429 1 1
2024-02-27 10-K 10-K 0000950170-24-021135 001-40532 24686798 34 11277111 1 1
2024-02-13 SEC STAFF LETTER filename1.pdf 9999999997-24-000304 333-275919 63385
2024-02-13 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2024-02-13 16:15:00 9999999995-24-000415 333-275919 24631705 33 1864
2024-02-13 424B3 424B3 0001193125-24-033857 333-275919 24626879 33 9377632
2024-02-09 CORRESP filename1.htm 0001193125-24-030364 10497
2024-02-09 CORRESP filename1.htm 0001193125-24-030359 15707
2024-02-09 S-4/A S-4/A 0001193125-24-030334 333-275919 24616248 33 23817144 1 1
2024-02-09 UPLOAD filename1.pdf 0000000000-24-001600 333-275919 41738
2024-02-05 CORRESP filename1.htm 0001193125-24-024152 30393
2024-02-05 S-4/A S-4/A 0001193125-24-024135 333-275919 24596567 33 24335684 1 1
2024-02-05 SC 13G b125243sc13g.htm 0001214659-24-001942 005-92660 24596474 34 96972
2024-02-05 SC 13G/A SC 13G/A 0001193125-24-024106 005-92660 24596182 34 44841
2024-02-01 SEC STAFF LETTER filename1.pdf 9999999997-24-000233 65420
2024-02-01 UPLOAD filename1.pdf 0000000000-24-001242 333-275919 51608
2024-01-18 S-4/A S-4/A 0001193125-24-009463 333-275919 24539930 33 24104351 1 1
2024-01-17 CORRESP filename1.htm 0001193125-24-009465 81648
2024-01-05 UPLOAD filename1.pdf 0000000000-24-000159 333-275919 70939
2023-12-26 425 425 0001193125-23-303062 001-40532 231513746 34 30137
2023-12-26 8-K 8-K 8.01 0001193125-23-303051 001-40532 231513695 34 164479 1 1
2023-12-06 S-4 S-4 0001193125-23-289969 333-275919 231470331 33 25137541 1 1
2023-11-17 SC 13D/A SC 13D/A 0001193125-23-279834 005-92660 231419390 34 136549
2023-11-15 425 425 0001193125-23-277999 001-40532 231411660 34 40679
2023-11-15 425 425 0001193125-23-277556 001-40532 231409098 34 11285419
2023-11-15 8-K 8-K 1.01,3.02,5.01,5.02,7.01,9.01 0001193125-23-277555 001-40532 231409094 34 11756534 1 1
2023-11-13 10-Q 10-Q 0000950170-23-062942 001-40532 231398787 34 10261344 1 1
2023-10-30 8-K 8-K 1.01,9.01 0000950170-23-056341 001-40532 231360284 34 793117 1 1
2023-09-13 8-K/A 8-K/A 5.02 0000950170-23-047925 001-40532 231252754 34 176287 1 1
2023-08-23 8-K 8-K 2.05,5.02,8.01 0000950170-23-044135 001-40532 231197632 34 190431 1 1
2023-08-14 10-Q 10-Q 0000950170-23-042525 001-40532 231171792 34 10376427 1 1
2023-08-02 8-K 8-K 5.02 0000950170-23-037141 001-40532 231135544 34 173853 1 1
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044075 5570
2023-08-01 3 FORM 3 SUBMISSION 0001209191-23-044074 7395
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043145 5615
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043142 5602
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043140 5572
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043137 5568
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043134 5700
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043131 5763
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043129 5600
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043125 5591
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043123 5543
2023-07-20 8-K 8-K 5.07 0000950170-23-033594 001-40532 231098119 34 182755 1 1
2023-06-23 8-K 8-K 5.02,7.01,9.01 0000950170-23-029499 001-40532 231034858 34 206352 1 1
2023-06-06 ARS ARS 0000950170-23-026628 001-40532 23996275 34 3217762
2023-06-06 DEFA14A DEFA14A 0000950170-23-026627 001-40532 23996192 34 224762
2023-06-06 DEF 14A DEF 14A 0000950170-23-026624 001-40532 23996103 34 1046947
2023-05-11 10-Q 10-Q 0000950170-23-021242 001-40532 23911136 34 9191854 1 1
2023-04-27 10-K/A 10-K/A 0000950170-23-015258 001-40532 23856813 34 3634022 1 1
2023-03-20 S-8 S-8 0000950170-23-008770 333-270694 23746591 33 203723
2023-03-20 10-K 10-K 0000950170-23-008764 001-40532 23746493 34 18905908 1 1
2023-03-20 8-K 8-K 2.02,9.01 0000950170-23-008761 001-40532 23746442 34 549878 1 1
2023-03-16 8-K 8-K 5.02,9.01 0000950170-23-008443 001-40532 23738761 34 253218 1 1
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012264 5602
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012259 5632
2023-02-22 8-K 8-K 2.05,5.02,8.01,9.01 0000950170-23-003808 001-40532 23654273 34 222924 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021936 005-92660 23631351 34 113276
2023-01-09 SC 13G/A grph13ga.htm 0000935836-23-000016 005-92660 23518414 34 47168
2023-01-06 3 FORM 3 0001567619-23-000700 5255
2023-01-05 8-K 8-K 8.01,9.01 0000950170-23-000228 001-40532 23511302 34 212403 1 1
2022-12-12 SC 13G/A filing.txt 0000315066-22-001882 005-92660 221456270 34 8061
2022-12-12 8-K 8-K 8.01,9.01 0000950170-22-026333 001-40532 221456078 34 203969 1 1
2022-11-18 SC 13G graphitebio13g.htm 0000935836-22-000620 005-92660 221401397 34 47178
2022-11-09 10-Q 10-Q 0000950170-22-023869 001-40532 221372783 34 11496715 1 1
2022-11-09 8-K 8-K 2.02,9.01 0000950170-22-023837 001-40532 221372593 34 574962 1 1
2022-11-03 8-K 8-K 8.01,9.01 0000950170-22-021600 001-40532 221356462 34 208075 1 1
2022-08-11 10-Q 10-Q 0000950170-22-016869 001-40532 221155894 34 10437207 1 1
2022-08-11 8-K 8-K 2.02,9.01 0000950170-22-016857 001-40532 221155733 34 542019 1 1
2022-08-11 8-K 8-K 8.01,9.01 0000950170-22-016657 001-40532 221153751 34 212897 1 1
2022-07-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-07-28 16:00:00 9999999995-22-002198 333-266262 221117110 33 1814
2022-07-26 UPLOAD filename1.pdf 0000000000-22-007822 40259
2022-07-26 CORRESP filename1.htm 0001193125-22-201400 6587
2022-07-21 S-3 S-3 0001193125-22-199216 333-266262 221097510 33 1463645
2022-07-13 8-K/A 8-K/A 8.01,9.01 0001193125-22-192923 001-40532 221081346 34 184335 1 1
2022-06-23 8-K 8-K 5.07 0001193125-22-180184 001-40532 221035816 34 158480 1 1
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038736 9999
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038735 9986
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038734 9954
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038733 9950
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038732 10076
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038730 10143
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038729 9982
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038727 9967
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038725 9921
2022-05-16 8-K 8-K 2.02,9.01 0001564590-22-020233 001-40532 22925169 34 197586 1 1
2022-05-12 10-Q 10-Q 0001564590-22-019862 001-40532 22917933 34 8773320 1 1
2022-05-12 8-K 8-K 2.02,9.01 0001564590-22-019849 001-40532 22917772 34 448685 1 1
2022-04-29 DEFA14A DEFA14A 0001193125-22-133632 001-40532 22875328 34 904801
2022-04-29 DEF 14A DEF 14A 0001193125-22-133540 001-40532 22875114 34 1220453
2022-04-13 4 FORM 4 SUBMISSION 0001209191-22-024364 10927
2022-04-13 4 FORM 4 SUBMISSION 0001209191-22-024362 4860
2022-04-05 4 FORM 4 SUBMISSION 0001209191-22-023268 5663
2022-04-05 3 FORM 3 SUBMISSION 0001209191-22-023259 7497
2022-03-21 S-8 REGISTRATION STATEMENT ON FORM S-8 0001193125-22-080574 333-263747 22755987 33 80109
2022-03-21 10-K 10-K 0001564590-22-011123 001-40532 22754282 34 18086116 1 1
2022-03-21 8-K 8-K 2.02,9.01 0001564590-22-011122 001-40532 22754272 34 561458 1 1
2022-03-02 8-K 8-K 5.02,9.01 0001564590-22-008273 001-40532 22703407 34 198364 1 1
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011470 10062
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011465 9961
2022-02-14 SC 13G SC 13G 0001193125-22-041787 005-92660 22632381 34 43110
2022-02-14 SC 13G/A SC 13G 0001104659-22-021026 005-92660 22624483 34 112838
2022-02-09 SC 13G/A filing.txt 0000315066-22-001031 005-92660 22604353 34 8566
2022-01-25 4 FORM 4 SUBMISSION 0001209191-22-004735 10882
2022-01-21 4 FORM 4 SUBMISSION 0001209191-22-004346 10881
2021-12-20 8-K 8-K 1.01,2.03,9.01 0001564590-21-060737 001-40532 211505330 34 3328571 1 1
2021-12-20 4 FORM 4 SUBMISSION 0001209191-21-070500 8672
2021-12-08 8-K DEPARTURE OF DIRECTOR OR CERTAIN OFFICER 5.02 0001564590-21-059679 001-40532 211477564 34 197541 1 1
2021-11-24 4 FORM 4 SUBMISSION 0001209191-21-066742 8665
2021-11-17 8-K 8-K 7.01,8.01,9.01 0001564590-21-057384 001-40532 211418631 34 197102 1 1
2021-11-16 8-K 8-K 1.01,2.03,9.01 0001564590-21-057277 001-40532 211415981 34 1120686 1 1
2021-11-10 10-Q 10-Q 0001564590-21-056184 001-40532 211396671 34 10833351 1 1
2021-11-10 8-K 8-K - Q3 2.02,9.01 0001564590-21-056172 001-40532 211396492 34 562611 1 1
2021-10-15 4 FORM 4 SUBMISSION 0001209191-21-060627 12556
2021-10-12 SC 13G filing.txt 0000315066-21-001804 005-92660 211317251 34 8575
2021-10-08 4 FORM 4 SUBMISSION 0001209191-21-060060 13079
2021-08-12 10-Q 10-Q 0001564590-21-043980 001-40532 211167707 34 10059111 1 1
2021-08-12 8-K 8-K 2.02,9.01 0001564590-21-043954 001-40532 211167498 34 496939 1 1
2021-07-09 SC 13D SC 13D 0001193125-21-211911 005-92660 211083254 34 140162
2021-07-09 SC 13G SC 13G 0001104659-21-090669 005-92660 211083158 34 111492
2021-07-01 4 FORM 4 SUBMISSION 0000899243-21-027018 23718
2021-07-01 4 FORM 4 SUBMISSION 0000899243-21-027015 18505
2021-07-01 4 FORM 4 SUBMISSION 0000899243-21-027017 15115
2021-07-01 4 FORM 4 SUBMISSION 0000899243-21-027014 8685
2021-07-01 4 FORM 4 SUBMISSION 0000899243-21-027016 26530
2021-07-01 4 FORM 4 SUBMISSION 0000899243-21-027013 19451
2021-07-01 4 FORM 4 SUBMISSION 0000899243-21-027012 15437
2021-07-01 4 FORM 4 SUBMISSION 0000899243-21-027011 22546
2021-07-01 4 FORM 4 SUBMISSION 0001209191-21-044507 23178
2021-06-30 8-K 8-K 1.01,5.03,9.01 0001193125-21-204869 001-40532 211062781 34 346349
2021-06-28 4 FORM 4 SUBMISSION 0000899243-21-026342 5724
2021-06-28 4 FORM 4 SUBMISSION 0000899243-21-026340 12839
2021-06-28 4 FORM 4 SUBMISSION 0000899243-21-026339 5561
2021-06-28 S-8 S-8 0001193125-21-202189 333-257486 211054626 33 81872
2021-06-28 424B4 424B4 0001193125-21-200751 333-256838 211049667 33 5887666
2021-06-24 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-06-24 16:00:00 9999999995-21-002503 333-256838 211044583 33 1826
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025857 16964
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025853 9279
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025851 11125
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025850 13174
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025848 11260
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025847 7989
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025842 11161
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025841 7828
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025840 8454
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025839 12529
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025837 12764
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025835 9312
2021-06-24 3 FORM 3 SUBMISSION 0000899243-21-025834 9234
2021-06-24 3 FORM 3 SUBMISSION 0001209191-21-043152 11191
2021-06-24 S-1MEF S-1MEF 0001193125-21-198924 333-257370 211044122 33 48839
2021-06-24 CERT 8A_Cert_GRPH.pdf 0001354457-21-000707 001-40532 211043247 34 238327
2021-06-24 SEC STAFF LETTER filename1.pdf 9999999997-21-003625 271992
2021-06-22 8-A12B 8-A12B 0001193125-21-196381 001-40532 211036366 34 13670
2021-06-22 CORRESP filename1.htm 0001193125-21-196376 11453
2021-06-22 CORRESP filename1.htm 0001193125-21-196371 9189
2021-06-22 CORRESP filename1.htm 0001193125-21-196306 19248
2021-06-22 S-1/A S-1/A 0001193125-21-196288 333-256838 211035840 33 5982444
2021-06-22 UPLOAD filename1.pdf 0000000000-21-007642 43731
2021-06-21 S-1/A S-1/A 0001193125-21-194083 333-256838 211027265 33 7457561
2021-06-15 SEC STAFF LETTER filename1.pdf 9999999997-21-003437 272999
2021-06-11 CORRESP filename1.htm 0001193125-21-189013 19792
2021-06-11 S-1/A S-1/A 0001193125-21-189004 333-256838 211012248 33 6391476
2021-06-10 CORRESP filename1.htm 0001193125-21-188081 88956
2021-06-07 UPLOAD filename1.pdf 0000000000-21-007021 45988
2021-06-04 S-1 S-1 0001193125-21-183167 333-256838 21997555 33 8887170
2021-05-21 DRSLTR filename1.htm 0000950123-21-007275 56960
2021-05-21 DRS/A filename1.htm 0000950123-21-007270 377-04677 21950287 33 8725582
2021-05-14 UPLOAD filename1.pdf 0000000000-21-006170 62902
2021-04-16 DRS filename1.htm 0000950123-21-004654 377-04677 21832475 33 5186230
2021-03-19 D xslFormDX01/primary_doc.xml 06b 0001815776-21-000002 021-392907 21757773 33 13660

Latest XBRL company facts

One latest value per concept from companyfacts (263 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 31.42M 2026-10-28 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
dei EntityPublicFloat Entity Public Float USD 690.10M 2025-06-30 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.52M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 913,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 486,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 1.53M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 777,000 2024-03-31 2024 Q1 10-Q 2024-05-08 0001815776-24-000042
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 12.23M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.03M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 355,000 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.06M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 524.57M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.13M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.92M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap AdvertisingExpense Advertising Expense USD 36.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap Assets Assets USD 209.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AssetsCurrent Assets, Current USD 206.90M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AssetsHeldForSaleLongLivedFairValueDisclosure Assets Held-for-sale, Long Lived, Fair Value Disclosure USD 20,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062942
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 2.70M 2023-06-30 2023 Q2 10-Q 2023-08-14 0000950170-23-042525
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 236.87M 2022-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost USD 123.58M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 123.09M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost USD 44.23M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value USD 43.66M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 176.06M 2024-09-30 2024 Q3 10-Q 2024-11-06 0001815776-24-000071
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 176.06M 2024-09-30 2024 Q3 10-Q 2024-11-06 0001815776-24-000071
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001815776-26-000052
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 30.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 29.90M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 197.30M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 25.18M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 30.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 5.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 6.41M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 31.42M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 31.42M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -105.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 0 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 0 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062942
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 785,000 2026-06-30 2026 Q2 10-Q 2026-08-11 0001815776-26-000052
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0000950170-23-008764
us-gaap ConvertiblePreferredStockConvertedToOtherSecurities Convertible Preferred Stock Converted to Other Securities USD 260.50M 2021-06-28 2022 FY 10-K 2023-03-20 0000950170-23-008764
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CostsAndExpenses Costs and Expenses USD 122.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 502,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss USD 175.54M 2024-09-30 2024 Q3 10-Q 2024-11-06 0001815776-24-000071
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss USD 167.81M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 15.30M 2022-12-31 2022 FY 10-K 2023-03-20 0000950170-23-008764
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 51.00M 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062942
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 166.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent USD 166.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 166.80M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions position 95 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-19 0001815776-25-000019
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 488,000 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2021-12-31 2021 FY 10-K 2022-03-21 0001564590-22-011123
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 70.80M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 488,000 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 38.20M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.96M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 6.16M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness Deferred Tax Assets, Tax Credit Carryforwards, General Business USD 7.20M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 8.92M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.02M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 295,000 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 70.31M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 90.70M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 73,000 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 488,000 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DefinedBenefitPlanSpecialTerminationBenefits Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits USD 1.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 21,000 2024-03-31 2024 Q1 10-Q 2024-05-08 0001815776-24-000042
us-gaap Depreciation Depreciation USD 2.40M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2.41M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 330,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.48 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019862
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.196 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 5.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 35.80M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023869
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 1.10M 2025-12-31 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -71,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -71,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 40.97M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 253,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -104.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 502,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 16.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -17.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 282,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -71,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 263,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 114,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 763,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 584,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -4.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncreaseDecreaseInAssetsHeldForSale Increase (Decrease) in Assets Held-for-sale USD 20,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062942
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 785,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001815776-26-000052
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -2.27M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -54,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap InsuranceRecoveries Insurance Recoveries USD 300,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001815776-26-000052
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 40,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-21 0001564590-22-011123
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 1.71M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap InventoryNet Inventory, Net USD 4.76M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 610,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 3.05M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap InventoryWriteDown Inventory Write-down USD 556,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 6.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.078 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 480,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 361,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 361,000 2024-09-30 2024 Q3 10-Q 2024-11-06 0001815776-24-000071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 361,000 2025-09-30 2025 Q3 10-Q 2025-11-05 0001815776-25-000071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 362,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001815776-26-000037
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 119,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 20,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap Liabilities Liabilities USD 17.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 209.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap LiabilitiesCurrent Liabilities, Current USD 17.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 409,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 99.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -94.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -104.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap NoncashMergerRelatedCosts Noncash Merger Related Costs USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-30 0001815776-25-000056
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap OperatingExpenses Operating Expenses USD 70.17M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001815776-25-000071
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -111.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OperatingLeaseCost Operating Lease, Cost USD 7.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 460,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 460,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OperatingLeasePayments Operating Lease, Payments USD 44.12M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 421,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 559,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 56.62M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.79M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OtherLiabilities Other Liabilities USD 0 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062942
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-19 0001815776-25-000019
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.38M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-19 0001815776-25-000019
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 32.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 28.13M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 34,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.92M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap PrepaidInsurance Prepaid Insurance USD 780,000 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0000950170-23-008764
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-07 0001815776-25-000032
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-19 0001815776-25-000019
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0000950170-23-008764
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 132.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 5.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-21 0001564590-22-011123
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 263.43M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap ProceedsFromSaleOfOtherPropertyPlantAndEquipment Proceeds from Sale of Other Property, Plant, and Equipment USD 1.90M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 395,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -124.65M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.54M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 640,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap RestrictedCash Restricted Cash USD 100,000 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 1.60M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 114,000 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap RestructuringCosts Restructuring Costs USD 62.08M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 6.80M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062942
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -331.52M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 10.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 17.50M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001815776-25-000071
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 53.50M 2024-03-21 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 15.41M 2024-03-21 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap SaleOfStockPercentageOfOwnershipAfterTransaction Sale of Stock, Percentage of Ownership after Transaction pure 0.56 2024-03-21 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 19 2024-07-17 2024 FY 10-K 2025-03-19 0001815776-25-000019
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 120.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap SeveranceCosts1 Severance Costs USD -6.57M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 12.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0000950170-23-042525
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 564,000 2023-01-01 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.89M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023869
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.56 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 12.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023869
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1 2020-06-30 2022 FY 10-K 2023-03-20 0000950170-23-008764
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 192.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 8.67M 2024-03-21 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 55,047 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0000950170-23-042525
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 143.39M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 395,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 26.07M 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 14,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap Supplies Prepaid Supplies USD 0 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-19 0001815776-25-000019
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2024-03-20 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 53.76M 2024-03-20 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 10.00M 2020-06-30 2022 FY 10-K 2023-03-20 0000950170-23-008764
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 1.05M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 4.42M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 146,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 42,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 3.70M 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 17.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001815776-26-000011
us-gaap VariableLeaseCost Variable Lease, Cost USD 2.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 7.27M 2020-03-01 2020-03-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 31.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 54.01M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019862
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 58.05M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021135
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 31.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001815776-26-000059

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →